Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Bio-Path Holdings unveils preclinical success for BP1001-A in treating obesity and Type 2 diabetes
Bio-Path Holdings, Inc. (NASDAQ: BPTH), a biotechnology innovator known for leveraging its DNAbilize liposomal delivery platform, has announced promising preclinical study results for BP1001-A, a ... Read More
Cognition Therapeutics reports promising Phase 2 results for CT1812 in dementia with Lewy bodies
Cognition Therapeutics, Inc. (NASDAQ: CGTX), a clinical-stage pharmaceutical company focused on neurodegenerative disorder treatment, has reported highly encouraging Phase 2 trial results for CT1812, a ... Read More
Polyrizon prepares for allergy blocker trial with strategic manufacturing partnership
Polyrizon Ltd., a biotech company known for its cutting-edge nasal hydrogel technology, has solidified its preparations for the anticipated 2025 allergy blocker trial by entering ... Read More
Corvus Pharmaceuticals shares surge ahead of Phase 1 data release for Soquelitinib
Corvus Pharmaceuticals, a clinical-stage biopharmaceutical company, is poised to announce interim results from its Phase 1 trial evaluating soquelitinib as a potential treatment for moderate ... Read More
Tenaya Therapeutics’ TN-201 demonstrates tolerability and protein expression in early HCM trial
Tenaya Therapeutics, a clinical-stage biotechnology company, has released promising interim results from its MyPEAK-1 Phase 1b/2 clinical trial evaluating TN-201 gene therapy for MYBPC3-associated hypertrophic ... Read More
Portage Biotech and Immunova sign LOI for potential iOx Therapeutics acquisition
Portage Biotech, Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company advancing innovative therapies to target cancer, has entered into a Letter of Intent (LOI) with Immunova, ... Read More
FDA acceptance propels Tonix Pharmaceuticals’ TNX-102 SL towards fibromyalgia treatment approval
Tonix Pharmaceuticals Holding Corp. has achieved a pivotal milestone with the FDA acceptance announcement for its New Drug Application (NDA) of TNX-102 SL, a novel ... Read More
Supriya Lifescience boosts API capacity with Rs 125cr Module E facility
Supriya Lifescience Ltd, a leading player in the pharmaceutical industry growth segment, has unveiled its latest Module E production block at its cutting-edge facility in ... Read More
Three biosimilars by Celltrion near EU approval following CHMP endorsement
Celltrion, a leading South Korean biopharmaceutical company, has received positive opinions from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) ... Read More
Gilead Sciences’ seladelpar gains support as PBC treatment in Europe
In a significant milestone for liver disease therapeutics, Gilead Sciences, Inc. has announced that the Committee for Medicinal Products for Human Use (CHMP) of the ... Read More